The official blog of the Lung Institute.

History of Stem Cell Therapy

23 Jun 2015
| Under COPD, Lung Disease | Posted by | 3 Comments
History of Stem Cell Therapy

The words “stem cell therapy” probably carry some sort of preconceived notions on your part. Whether you’ve heard stem cells mentioned as a political buzzword or in reference to new medical treatments, there is no denying the recent attention paid to these words. With the phenomenon recently growing around stem cells, many people assume the history of stem cell therapy is only a short-lived story. However, stem cell therapy has been conducted since the 1950s.

The First Stem Cell Therapy

Physicians have known for decades that leukemia affects the blood and specifically the production of white blood cells in the body. Dr. E. Donnall Thomas was on the forefront of bone marrow research, and in the late 1950s he discovered that transplanting bone marrow tissue, rich with stem cells, could help fight the disease. In Cooperstown, New York he performed the first bone marrow transplant between identical twins. Medical advancements at the time only allowed for an identical twin to donate bone marrow due to commonality of rejection.

Stem Cell Therapy in the ‘60s and ‘70s

A decade after Dr. Thomas performed the fist stem cell therapy, physicians developed protocols that allowed for the first allogeneic transplant, or transplant between two people that were not twins. However, even in this case, the donor was a sibling of the transplant recipient. It wasn’t until 1973 that the first non-related transplant took place. By this time, a blood bank in Denmark was able to match a donor and recipient.

Stem Cell Therapy Today

When the body becomes injured or develops a disease, stem cells are carried through the blood to the area and begin a natural healing process. They promote healing. Unfortunately this process is slow, and the healing may take longer than it takes the disease to progress and spread. For those suffering from leukemia, the replacement of diseased bone marrow with healthy tissue may help the body to help fight the disease. A similar positive reaction can be found for those who are suffering from lung diseases like chronic obstructive pulmonary disease (COPD) and interstitial lung disease.

Stem cells can be taken from the patient’s own body, eliminating the risk of rejection, processed in a lab, and then reintroduced into the body to help treat lung disease. This process gives the patient a stronger chance to expedite the healing process. Although this treatment does not cure the disease, many patients report an increased in quality of life, and some even show a return of lung function through their regular pulmonary function tests (PFTs).

If you or a loved one suffers from COPD or pulmonary fibrosis, the Lung Institute may be able to help. Contact us by calling (800) 729-3065 to pre-qualify for stem cell therapy and get your questions answered.



  1. phyllis

    3 years ago

    I am a 52-yearr-oqq aaã have complicated medical history. Shortest terms of medical hisrtory issues:
    1) auto immune disorder (connective tissue disorder’)
    2) Two thoracic abdominal aortic aneurysm repair surgeries (T/AAA). Aorta js graff
    3) Develoled MRSA after 1st surgery, aorta ruptured and second repair completed.
    4) Second procedure resulted in ESRD (on dialysis for 10 yesrs niow)
    5) receive 1.5 grams if vanco antibiotics with every hemodialysis treatment
    6) History of pe, dvft, and cervical blood clots –IVC filter in place
    7) fibromyalgia, Epstein Barr, hypothyroidism, hyperhomocysteinemia, depression, anxiety
    8) recurring issues of high bp and orthostatic hypotension
    9) suffer with RLS
    Would any of these issues disqualify me for stem cell therapy?

  2. David Ebner

    3 years ago


    Thanks for your comment. We’d love to chat with you more about your condition and how the Lung Institute may be able to help. Call us at (855) 313-1149 to talk with a patient coordinator and find out if you qualify for one of our treatment options.



  3. Sandra Smith

    3 years ago

    Am interested in this . I have COPD and my life isn’t at all the same…. Would do anything just to get alittle life back!!!! I miss living!!!

Your Comment

Your email address will not be published.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.